José-Ángel Hernández-Rivas

25PUBLICATIONS
285CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Natural language processingHaematological tumoursPlant and fungus systematics and taxonomy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 02, 2026
First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival.

|Oct 24, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies.

Dejan Juric, Daniel Anderson, Afshin Dowlati

|Dec 17, 2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study.

Pau Abrisqueta-Costa, José Antonio García-Marco, Antonio Gutiérrez

|Jan 23, 2024
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.

Joaquín Martínez-López, Javier de la Cruz, Rodrigo Gil-Manso

|Jan 22, 2024
Challenging Diagnosis of Invasive Sinus Aspergillosis Mimicking Gradenigo's Syndrome in an Elderly Patient with T-Cell Lymphoma.

Victoria Ramos de Ascanio, Gloria Liaño-Esteso, David Roldán

|Oct 28, 2023
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.

José Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello

Pageof 5

Frequent Collaborators

6 joint publications

Isabel González-Gascón-Y-Marín

5 joint publications

Alberto Lopez-Garcia

4 joint publications

Jose Antonio Garcia-Marco

4 joint publications

Monia Marchetti